Advanced Drug Delivery Systems-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
SKU ID :MI-11221913 | Published Date: 09-Nov-2017 | No. of pages: 148Description
TOC
Table of Contents
Chapter 1 Overview of Advanced Drug Delivery Systems
1.1 Definition of Advanced Drug Delivery Systems in This Report
1.2 Commercial Types of Advanced Drug Delivery Systems
1.2.1 Implants Drug Delivery
1.2.2 Parenteral/Injectable Drug Delivery
1.2.3 Topical Drug Delivery
1.2.4 Transdermal Drug Delivery
1.2.5 Oral Drug Delivery
1.2.6 Other
1.3 Downstream Application of Advanced Drug Delivery Systems
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Pharmaceutical Factory
1.3.4 Other
1.4 Development History of Advanced Drug Delivery Systems
1.5 Market Status and Trend of Advanced Drug Delivery Systems 2013-2023
1.5.1 Global Advanced Drug Delivery Systems Market Status and Trend 2013-2023
1.5.2 Regional Advanced Drug Delivery Systems Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Advanced Drug Delivery Systems 2013-2017
2.2 Sales Market of Advanced Drug Delivery Systems by Regions
2.2.1 Sales Volume of Advanced Drug Delivery Systems by Regions
2.2.2 Sales Value of Advanced Drug Delivery Systems by Regions
2.3 Production Market of Advanced Drug Delivery Systems by Regions
2.4 Global Market Forecast of Advanced Drug Delivery Systems 2018-2023
2.4.1 Global Market Forecast of Advanced Drug Delivery Systems 2018-2023
2.4.2 Market Forecast of Advanced Drug Delivery Systems by Regions 2018-2023
Chapter 3 Global Market Status and Forecast by Types
3.1 Sales Volume of Advanced Drug Delivery Systems by Types
3.2 Sales Value of Advanced Drug Delivery Systems by Types
3.3 Market Forecast of Advanced Drug Delivery Systems by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Global Sales Volume of Advanced Drug Delivery Systems by Downstream Industry
4.2 Global Market Forecast of Advanced Drug Delivery Systems by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
5.1 North America Advanced Drug Delivery Systems Market Status by Countries
5.1.1 North America Advanced Drug Delivery Systems Sales by Countries (2013-2017)
5.1.2 North America Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
5.1.3 United States Advanced Drug Delivery Systems Market Status (2013-2017)
5.1.4 Canada Advanced Drug Delivery Systems Market Status (2013-2017)
5.1.5 Mexico Advanced Drug Delivery Systems Market Status (2013-2017)
5.2 North America Advanced Drug Delivery Systems Market Status by Manufacturers
5.3 North America Advanced Drug Delivery Systems Market Status by Type (2013-2017)
5.3.1 North America Advanced Drug Delivery Systems Sales by Type (2013-2017)
5.3.2 North America Advanced Drug Delivery Systems Revenue by Type (2013-2017)
5.4 North America Advanced Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
6.1 Europe Advanced Drug Delivery Systems Market Status by Countries
6.1.1 Europe Advanced Drug Delivery Systems Sales by Countries (2013-2017)
6.1.2 Europe Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
6.1.3 Germany Advanced Drug Delivery Systems Market Status (2013-2017)
6.1.4 UK Advanced Drug Delivery Systems Market Status (2013-2017)
6.1.5 France Advanced Drug Delivery Systems Market Status (2013-2017)
6.1.6 Italy Advanced Drug Delivery Systems Market Status (2013-2017)
6.1.7 Russia Advanced Drug Delivery Systems Market Status (2013-2017)
6.1.8 Spain Advanced Drug Delivery Systems Market Status (2013-2017)
6.1.9 Benelux Advanced Drug Delivery Systems Market Status (2013-2017)
6.2 Europe Advanced Drug Delivery Systems Market Status by Manufacturers
6.3 Europe Advanced Drug Delivery Systems Market Status by Type (2013-2017)
6.3.1 Europe Advanced Drug Delivery Systems Sales by Type (2013-2017)
6.3.2 Europe Advanced Drug Delivery Systems Revenue by Type (2013-2017)
6.4 Europe Advanced Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
7.1 Asia Pacific Advanced Drug Delivery Systems Market Status by Countries
7.1.1 Asia Pacific Advanced Drug Delivery Systems Sales by Countries (2013-2017)
7.1.2 Asia Pacific Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
7.1.3 China Advanced Drug Delivery Systems Market Status (2013-2017)
7.1.4 Japan Advanced Drug Delivery Systems Market Status (2013-2017)
7.1.5 India Advanced Drug Delivery Systems Market Status (2013-2017)
7.1.6 Southeast Asia Advanced Drug Delivery Systems Market Status (2013-2017)
7.1.7 Australia Advanced Drug Delivery Systems Market Status (2013-2017)
7.2 Asia Pacific Advanced Drug Delivery Systems Market Status by Manufacturers
7.3 Asia Pacific Advanced Drug Delivery Systems Market Status by Type (2013-2017)
7.3.1 Asia Pacific Advanced Drug Delivery Systems Sales by Type (2013-2017)
7.3.2 Asia Pacific Advanced Drug Delivery Systems Revenue by Type (2013-2017)
7.4 Asia Pacific Advanced Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
8.1 Latin America Advanced Drug Delivery Systems Market Status by Countries
8.1.1 Latin America Advanced Drug Delivery Systems Sales by Countries (2013-2017)
8.1.2 Latin America Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
8.1.3 Brazil Advanced Drug Delivery Systems Market Status (2013-2017)
8.1.4 Argentina Advanced Drug Delivery Systems Market Status (2013-2017)
8.1.5 Colombia Advanced Drug Delivery Systems Market Status (2013-2017)
8.2 Latin America Advanced Drug Delivery Systems Market Status by Manufacturers
8.3 Latin America Advanced Drug Delivery Systems Market Status by Type (2013-2017)
8.3.1 Latin America Advanced Drug Delivery Systems Sales by Type (2013-2017)
8.3.2 Latin America Advanced Drug Delivery Systems Revenue by Type (2013-2017)
8.4 Latin America Advanced Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
9.1 Middle East and Africa Advanced Drug Delivery Systems Market Status by Countries
9.1.1 Middle East and Africa Advanced Drug Delivery Systems Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
9.1.3 Middle East Advanced Drug Delivery Systems Market Status (2013-2017)
9.1.4 Africa Advanced Drug Delivery Systems Market Status (2013-2017)
9.2 Middle East and Africa Advanced Drug Delivery Systems Market Status by Manufacturers
9.3 Middle East and Africa Advanced Drug Delivery Systems Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Advanced Drug Delivery Systems Sales by Type (2013-2017)
9.3.2 Middle East and Africa Advanced Drug Delivery Systems Revenue by Type (2013-2017)
9.4 Middle East and Africa Advanced Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
Chapter 10 Market Driving Factor Analysis of Advanced Drug Delivery Systems
10.1 Global Economy Situation and Trend Overview
10.2 Advanced Drug Delivery Systems Downstream Industry Situation and Trend Overview
Chapter 11 Advanced Drug Delivery Systems Market Competition Status by Major Manufacturers
11.1 Production Volume of Advanced Drug Delivery Systems by Major Manufacturers
11.2 Production Value of Advanced Drug Delivery Systems by Major Manufacturers
11.3 Basic Information of Advanced Drug Delivery Systems by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Advanced Drug Delivery Systems Major Manufacturer
11.3.2 Employees and Revenue Level of Advanced Drug Delivery Systems Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
Chapter 12 Advanced Drug Delivery Systems Major Manufacturers Introduction and Market Data
12.1 Abbott Laboratories
12.1.1 Company profile
12.1.2 Representative Advanced Drug Delivery Systems Product
12.1.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.2 Johnson & Johnson
12.2.1 Company profile
12.2.2 Representative Advanced Drug Delivery Systems Product
12.2.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.3 Pfizer
12.3.1 Company profile
12.3.2 Representative Advanced Drug Delivery Systems Product
12.3.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Pfizer
12.4 Sanofi SA
12.4.1 Company profile
12.4.2 Representative Advanced Drug Delivery Systems Product
12.4.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Sanofi SA
12.5 Janssen Biotech
12.5.1 Company profile
12.5.2 Representative Advanced Drug Delivery Systems Product
12.5.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Janssen Biotech
12.6 Kempharm
12.6.1 Company profile
12.6.2 Representative Advanced Drug Delivery Systems Product
12.6.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Kempharm
12.7 Mylan Laboratories
12.7.1 Company profile
12.7.2 Representative Advanced Drug Delivery Systems Product
12.7.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Mylan Laboratories
12.8 3M
12.8.1 Company profile
12.8.2 Representative Advanced Drug Delivery Systems Product
12.8.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of 3M
12.9 Allergan PLC
12.9.1 Company profile
12.9.2 Representative Advanced Drug Delivery Systems Product
12.9.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Allergan PLC
12.10 Baxter International
12.10.1 Company profile
12.10.2 Representative Advanced Drug Delivery Systems Product
12.10.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Baxter International
12.11 Capsugel
12.11.1 Company profile
12.11.2 Representative Advanced Drug Delivery Systems Product
12.11.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Capsugel
12.12 Genentech
12.12.1 Company profile
12.12.2 Representative Advanced Drug Delivery Systems Product
12.12.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Genentech
12.13 Generex Biotechnology
12.13.1 Company profile
12.13.2 Representative Advanced Drug Delivery Systems Product
12.13.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Generex Biotechnology
12.14 Theraject
12.14.1 Company profile
12.14.2 Representative Advanced Drug Delivery Systems Product
12.14.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Theraject
12.15 Valeant Pharmaceuticals International
12.15.1 Company profile
12.15.2 Representative Advanced Drug Delivery Systems Product
12.15.3 Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International
Chapter 13 Upstream and Downstream Market Analysis of Advanced Drug Delivery Systems
13.1 Industry Chain of Advanced Drug Delivery Systems
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Advanced Drug Delivery Systems
14.1 Cost Structure Analysis of Advanced Drug Delivery Systems
14.2 Raw Materials Cost Analysis of Advanced Drug Delivery Systems
14.3 Labor Cost Analysis of Advanced Drug Delivery Systems
14.4 Manufacturing Expenses Analysis of Advanced Drug Delivery Systems
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
Tables & Figures
List of Tables
Table Advantage and Disadvantage of Implants Drug Delivery
Table Advantage and Disadvantage of Parenteral/Injectable Drug Delivery
Table Advantage and Disadvantage of Topical Drug Delivery
Table Advantage and Disadvantage of Transdermal Drug Delivery
Table Advantage and Disadvantage of Oral Drug Delivery
Table Advantage and Disadvantage of Other
Table Sales Volume of Advanced Drug Delivery Systems by Regions 2013-2017
Table Sales Value of Advanced Drug Delivery Systems by Regions 2013-2017
Table Production Volume of Advanced Drug Delivery Systems by Regions 2013-2017
Table Global Sales Volume of Advanced Drug Delivery Systems by Regions 2018-2023
Table Global Sales Value of Advanced Drug Delivery Systems by Regions 2018-2023
Table Global Production Volume of Advanced Drug Delivery Systems by Regions 2018-2023
Table Sales Volume of Advanced Drug Delivery Systems by Types 2013-2017
Table Sales Value of Advanced Drug Delivery Systems by Types 2013-2017
Table Sales Volume Forecast of Advanced Drug Delivery Systems by Types 2018-2023
Table Sales Value Forecast of Advanced Drug Delivery Systems by Types 2018-2023
Table Sales Volume of Advanced Drug Delivery Systems by Downstream Industry 2013-2017
Table Sales Volume Forecast of Advanced Drug Delivery Systems by Downstream Industry 2018-2023
Table North America Advanced Drug Delivery Systems Sales by Countries (2013-2017)
Table North America Advanced Drug Delivery Systems Sales Share by Countries (2013-2017)
Table North America Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
Table North America Advanced Drug Delivery Systems Revenue Market Share by Countries (2013-2017)
Table North America Advanced Drug Delivery Systems Sales by Type (2013-2017)
Table North America Advanced Drug Delivery Systems Sales Share by Type (2013-2017)
Table North America Advanced Drug Delivery Systems Revenue by Type (2013-2017)
Table North America Advanced Drug Delivery Systems Revenue Share by Type (2013-2017)
Table North America Advanced Drug Delivery Systems Sales by Downstream Industry (2013-2017)
Table North America Advanced Drug Delivery Systems Sales Share by Downstream Industry (2013-2017)
Table Europe Advanced Drug Delivery Systems Sales by Countries (2013-2017)
Table Europe Advanced Drug Delivery Systems Sales Share by Countries (2013-2017)
Table Europe Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
Table Europe Advanced Drug Delivery Systems Revenue Market Share by Countries (2013-2017)
Table Europe Advanced Drug Delivery Systems Sales by Type (2013-2017)
Table Europe Advanced Drug Delivery Systems Sales Share by Type (2013-2017)
Table Europe Advanced Drug Delivery Systems Revenue by Type (2013-2017)
Table Europe Advanced Drug Delivery Systems Revenue Share by Type (2013-2017)
Table Europe Advanced Drug Delivery Systems Sales by Downstream Industry (2013-2017)
Table Europe Advanced Drug Delivery Systems Sales Share by Downstream Industry (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Sales by Countries (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Sales Share by Countries (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Revenue Market Share by Countries (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Sales by Type (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Sales Share by Type (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Revenue by Type (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Revenue Share by Type (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Sales by Downstream Industry (2013-2017)
Table Asia Pacific Advanced Drug Delivery Systems Sales Share by Downstream Industry (2013-2017)
Table Latin America Advanced Drug Delivery Systems Sales by Countries (2013-2017)
Table Latin America Advanced Drug Delivery Systems Sales Share by Countries (2013-2017)
Table Latin America Advanced Drug Delivery Systems Revenue by Countries (2013-2017)
Table Latin America Advanced Drug Delivery Systems Revenue Market Share by Countries (2013-2017)
Table Latin America Advanced Drug Delivery Systems Sales by Type (2013-2017)
Table Latin America Advanced Drug Delivery Systems Sales Share by Type (2013-2017)
Table Latin America Advanced Drug Delivery Systems Revenue by Type (2013-2017)
Table Latin America Advanced Drug Delivery Systems Revenue Share by Type (2013-2017)
Table Latin America Advanced Drug Delivery Systems Sales by Downstream Industry (2013-2017)
Table Latin America Advanced Drug Delivery Systems Sales Share by Downstream Industry (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Sales by Regions (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Sales Share by Regions (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Revenue by Regions (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Revenue Market Share by Regions (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Sales by Type (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Sales Share by Type (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Revenue by Type (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Revenue Share by Type (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Sales by Downstream Industry (2013-2017)
Table Middle East and Africa Advanced Drug Delivery Systems Sales Share by Downstream Industry (2013-2017)
Table Production Volume of Advanced Drug Delivery Systems by Major Manufacturers 2013-2017
Table Production Value of Advanced Drug Delivery Systems by Major Manufacturers 2013-2017
Table Headquarters Location and Established Time of Advanced Drug Delivery Systems Major Manufacturer
Table Employees and Revenue Level of Advanced Drug Delivery Systems Major Manufacturer
Table Representative Advanced Drug Delivery Systems Product One of Abbott Laboratories
Table Representative Advanced Drug Delivery Systems Product Two of Abbott Laboratories
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Abbott Laboratories 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Johnson & Johnson
Table Representative Advanced Drug Delivery Systems Product Two of Johnson & Johnson
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Pfizer
Table Representative Advanced Drug Delivery Systems Product Two of Pfizer
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Sanofi SA
Table Representative Advanced Drug Delivery Systems Product Two of Sanofi SA
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Sanofi SA 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Janssen Biotech
Table Representative Advanced Drug Delivery Systems Product Two of Janssen Biotech
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Janssen Biotech 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Kempharm
Table Representative Advanced Drug Delivery Systems Product Two of Kempharm
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Kempharm 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Mylan Laboratories
Table Representative Advanced Drug Delivery Systems Product Two of Mylan Laboratories
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Mylan Laboratories 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of 3M
Table Representative Advanced Drug Delivery Systems Product Two of 3M
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of 3M 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Allergan PLC
Table Representative Advanced Drug Delivery Systems Product Two of Allergan PLC
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Allergan PLC 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Baxter International
Table Representative Advanced Drug Delivery Systems Product Two of Baxter International
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Baxter International 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Capsugel
Table Representative Advanced Drug Delivery Systems Product Two of Capsugel
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Capsugel 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Genentech
Table Representative Advanced Drug Delivery Systems Product Two of Genentech
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Genentech 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Generex Biotechnology
Table Representative Advanced Drug Delivery Systems Product Two of Generex Biotechnology
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Generex Biotechnology 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Theraject
Table Representative Advanced Drug Delivery Systems Product Two of Theraject
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Theraject 2013-2017
Table Representative Advanced Drug Delivery Systems Product One of Valeant Pharmaceuticals International
Table Representative Advanced Drug Delivery Systems Product Two of Valeant Pharmaceuticals International
Table Advanced Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals International 2013-2017
Companies
- PRICE
-
$3680$6480